Sarasin & Partners’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $2.83M | Buy |
40,470
+17,900
| +79% | +$1.34M | 0.03% | 80 |
|
|
2026
Q2 | $1.62M | Buy |
22,570
+1,200
| +6% | +$113K | 0.02% | 79 |
|
|
2026
Q1 | $2.53M | Sell |
21,370
-1,049,188
| -98% | -$130M | 0.03% | 65 |
|
|
2025
Q4 | $135M | Sell |
1,070,558
-579,388
| -35% | -$75.6M | 1.4% | 30 |
|
|
2025
Q3 | $236M | Buy |
1,649,946
+38,367
| +2% | +$5.8M | 2.32% | 18 |
|
|
2025
Q2 | $251M | Buy |
1,611,579
+57,724
| +4% | +$9.15M | 2.5% | 14 |
|
|
2025
Q1 | $256M | Buy |
+1,553,855
| New | +$258M | 2.77% | 13 |
|
|
2024
Q4 | – | Sell |
-2,059,588
| Closed | -$402M | – | 86 |
|
|
2024
Q3 | $402M | Sell |
2,059,588
-194,002
| -9% | -$35.7M | 3.8% | 7 |
|
|
2024
Q2 | $391M | Buy |
2,253,590
+1,904,899
| +546% | +$317M | 3.46% | 10 |
|
|
2024
Q1 | $59M | Buy |
348,691
+142,496
| +69% | +$26.7M | 0.58% | 35 |
|
|
2023
Q4 | $40.7M | Sell |
206,195
-33
| -0% | -$5.84K | 0.45% | 38 |
|
|
2023
Q3 | $35.9M | Buy |
206,228
+52,691
| +34% | +$9.6M | 0.45% | 38 |
|
|
2023
Q2 | $26.4M | Buy |
153,537
+37,167
| +32% | +$6.43M | 0.31% | 42 |
|
|
2023
Q1 | $19.4M | Sell |
116,370
-7,292
| -6% | -$1.2M | 0.24% | 50 |
|
|
2022
Q4 | $18.1M | Sell |
123,662
-1,135
| -0.9% | -$168K | 0.24% | 54 |
|
|
2022
Q3 | $18.5M | Buy |
124,797
+5,000
| +4% | +$836K | 0.26% | 56 |
|
|
2022
Q2 | $20.6M | Sell |
119,797
-10,288
| -8% | -$1.78M | 0.26% | 57 |
|
|
2022
Q1 | $24.5M | Sell |
130,085
-67,855
| -34% | -$13.4M | 0.25% | 59 |
|
|
2021
Q4 | $48.3M | Hold |
197,940
| – | – | 0.44% | 49 |
|
|
2021
Q3 | $38.4M | Hold |
197,940
| – | – | 0.39% | 50 |
|
|
2021
Q2 | $36.9M | Buy |
197,940
+64,154
| +48% | +$11.1M | 0.39% | 46 |
|
|
2021
Q1 | $21.1M | Buy |
133,786
+52,611
| +65% | +$8.34M | 0.25% | 56 |
|
|
2020
Q4 | $13.4M | Hold |
81,175
| – | – | 0.18% | 62 |
|
|
2020
Q3 | $13.4M | Buy |
81,175
+14,839
| +22% | +$2.28M | 0.19% | 60 |
|
|
2020
Q2 | $9.09M | Hold |
66,336
| – | – | 0.15% | 68 |
|
|
2020
Q1 | $7.81M | Buy |
66,336
+7,517
| +13% | +$990K | 0.15% | 65 |
|
|
2019
Q4 | $7.78M | Hold |
58,819
| – | – | 0.12% | 82 |
|
|
2019
Q3 | $7.33M | Buy |
58,819
+9,873
| +20% | +$1.19M | 0.12% | 80 |
|
|
2019
Q2 | $5.56M | Buy |
48,946
+2,125
| +5% | +$223K | 0.1% | 86 |
|
|
2019
Q1 | $4.71M | Hold |
46,821
| – | – | 0.09% | 88 |
|
|
2018
Q4 | $4M | Sell |
46,821
-5,793
| -11% | -$522K | 0.09% | 87 |
|
|
2018
Q3 | $4.82M | Buy |
+52,614
| New | +$4.67M | 0.09% | 88 |
|
Other funds holding ZTS
Sarasin & Partners's ZTS Position: Q3 2026 in Review
Sarasin & Partners increased its Zoetis (ZTS) stake by 79% in Q3 2026, buying an estimated $1.34M and bringing the position to 40,470 shares worth $2.83M. The position accounts for 0.03% of the portfolio, ranked #80.
Sarasin & Partners first reported a position in ZTS in Q3 2018 and has held it in 32 quarters since. The position peaked at $402M in Q3 2024. 324 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.
- Sarasin & Partners held 40,470 shares of Zoetis worth $2.83M as of Q3 2026.
- Sarasin & Partners bought 17,900 Zoetis shares in Q3 2026, an estimated $1.34M.
- Zoetis made up 0.03% of Sarasin & Partners's portfolio in Q3 2026, its #80 holding.
- Sarasin & Partners first reported a position in Zoetis in Q3 2018 and has held it in 32 quarters since.
- Sarasin & Partners's Zoetis position peaked at $402M in Q3 2024.
- 324 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.
Based on Sarasin & Partners's 13F filing for Q3 2026, filed 13 Oct 2026.